⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DYAI News
Dyadic International, Inc.
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
globenewswire.com
DYAI
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
globenewswire.com
DYAI
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
globenewswire.com
DYAI
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
globenewswire.com
DYAI
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
accessnewswire.com
DGXX
DYAI
STRT
GAME
ACNT
RNXT
DCGO
BOSC
SCNX
ELWT
MOB
VELO
FLUX
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
accessnewswire.com
DYAI
STRT
GAME
ACNT
RNXT
DCGO
BOSC
SCNX
ELWT
MOB
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
globenewswire.com
DYAI
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
globenewswire.com
DYAI
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
globenewswire.com
DYAI
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
globenewswire.com
DYAI